Postoperative sleep disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. No contraindications to anaesthesia, no serious pre-operative underlying diseases, no cardiac, hepatic or renal dysfunction, etc. 2. Female patients 3. Elective surgery patients who are going to undergo breast cancer surgery, including total mastectomy, partial mastectomy, breast-conserving surgery, breast reconstruction surgery, and breast lymph node dissection. 4. Age 18-55 years old, ASA grade I-II 5. Patients with normal hearing, without bilateral deafness or severe hearing impairment. 6. No history of mental illness (e.g., depression, anxiety, schizophrenia, etc.) or neurological disease (e.g., epilepsy, Parkinson's disease, etc.), and not currently receiving any medication that may affect the function of the central nervous system. 7. No history of long-term use of psychoactive drugs (e.g., antidepressants, antipsychotics, benzodiazepines, etc.) or narcotic drug addiction. 8. No history of chronic sleep disorders, such as insomnia, sleep apnea syndrome, etc., and have not received any form of sleep therapy in the last month. 9. No serious cardiovascular, respiratory, hepatic or renal dysfunction, such as heart failure, severe chronic obstructive pulmonary disease, end-stage renal disease, etc. 10. No recent (past 6 months) history of major surgery or trauma. 11. Patients with early or intermediate stage breast cancer without distant metastasis. 12. Patients voluntarily sign an informed consent form, indicating that they understand the content of the study, the possible risks and benefits, and that they are willing to participate in the entire study process.
Exclusion criteria
Exclusion criteria: 1. Any patient with contraindications to surgery or anaesthesia. 2. Patients with anaemia (haemoglobin level below normal range), hypocalcaemia, hypomagnesaemia. 3. Patients with abnormal blood glucose, including patients with poorly controlled diabetes or a history of hypoglycaemia (blood glucose <= 3.9 mmol/L). 4. Patients with hyperthyroidism (hyperthyroidism). 5. Patients who are unwilling or unable to co-operate with the requirements of the study before or after surgery. 6. Patients who have received radiotherapy or chemotherapy that may affect the effectiveness of anaesthesia or study interventions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative sleep quality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Power spectral density of different EEG waveforms;Explosion inhibition ratio;Intraoperative dosage of vasoactive drugs; | — |
Countries
China
Contacts
Liaoning Cancer Hospital & Institute